Table 3 Risk factors for severity of Patients with COVID-19 at admission
Variables | Unadjusted model | Adjusted model | ||
|---|---|---|---|---|
OR (95%CI) | P-value | OR (95%CI) | P-value | |
Age (years) | 1.024 (1.001–1.048) | 0.044 | 1.035 (1.056–1.014) | 0.001 |
Male | 1.714 (0.967–3.037) | 0.065 | 1.970 (3.178–1.222) | 0.005 |
Comorbidity | ||||
Diabetes, n (%) | 0.759 (0.379–1.519) | 0.436 | 0.708 (1.203–0.417) | 0.202 |
Hypertension, n (%) | 0.598 (0.339–1.055) | 0.076 | 0.541 (0.884 − 0.331) | 0.014 |
Coronary Heart Disease n (%) | 0.730 (0.384–1.387) | 0.336 | 0.945 (1.629–0.549) | 0.839 |
Laboratory findings | ||||
Serum 25(OH)D level (ng/mL) | 0.986 (0.973–0.998) | 0.024 | 0.987 (0.998 − 0.977) | 0.022 |
Neutrophils, E + 09/L | 1.024(0.941–1.114) | 0.582 | ||
Lymphocytes, E + 09/L | 0.984 (0.837–1.154) | 0.830 | ||
Eosinophil, E + 09/L | 0.005 (2.024E-5-1.081) | 0.053 | ||
CRP, mg/L | 1.004 (1.000-1.009) | 0.057 | ||
D-dimer, µg/mL | 1.024 (0.976–1.076) | 0.333 | ||
Ferritin, ng/mL | 1 (0.999–1.001) | 0.53 | ||
Uric acid, µmol/L | 1.001 (0.998–1.003) | 0.597 | ||
LDH, U/L | 1.005 (1.002–1.007) | 0.000 | ||
Glucose, mmol/L | 0.975 (0.893–1.065) | 0.574 | ||
IL-5, pg/mL | 1.239 (1.104–1.391) | 0.000 | 1.207 (1.327–1.098) | 0.000 |
IL-6, pg/mL | 0.999 (0.988–1.010) | 0.999 | ||
IL-10, pg/mL | 1.011 (0.945–1.083) | 0.743 | ||
CD4+T | 1 (0.998–1.002) | 0.881 | ||
CD8+T | 0.998 (0.996-1) | 0.039 | 0.997 (0.998 − 0.995) | 0.000 |
B cells count | 1 (0.997–1.003) | 0.852 | ||